Preference for United States Industry. 25.1 Because this Agreement grants the exclusive right to use or sell the Invention in the United States, LICENSEE agrees that any products sold in the U.S. embodying this Invention or produced through the use thereof shall be manufactured substantially in the United States.
Appears in 3 contracts
Sources: License Agreement (Signal Pharmaceuticals Inc), License Agreement (Signal Pharmaceuticals Inc), License Agreement (Signal Pharmaceuticals Inc)
Preference for United States Industry. 25.1 Because this Agreement grants the exclusive right to use or sell the Invention in the United States, LICENSEE the Licensee agrees that any products sold in the U.S. embodying this Invention or produced through the use thereof shall will be manufactured substantially in the United States.
Appears in 3 contracts
Sources: Exclusive License Agreement (Urogen Corp), Exclusive License Agreement (Xxsys Technologies Inc /Ca), Exclusive License Agreement (Dynavax Technologies Corp)
Preference for United States Industry. 25.1 25. 1 Because this Agreement grants the exclusive right to use or sell the Invention Inventions in the United States, LICENSEE the Licensee agrees that any products sold in the U.S. embodying this Invention these Inventions or produced through the use thereof shall will be manufactured substantially in the United States.
Appears in 3 contracts
Sources: Exclusive License Agreement (Signal Pharmaceuticals Inc), Exclusive License Agreement (Signal Pharmaceuticals Inc), Exclusive License Agreement (Signal Pharmaceuticals Inc)
Preference for United States Industry. 25.1 Because this Agreement grants the exclusive right to use or sell the Invention in the United States, LICENSEE Licensee agrees that any products sold in the U.S. embodying this Invention or produced product through the use thereof shall thereof, which are intended to be used or sold in the United States, will be manufactured substantially in the United States.
Appears in 2 contracts
Sources: Exclusive License Agreement (Mgi Pharma Inc), Development, Marketing and Cooperation Agreement (Mgi Pharma Inc)
Preference for United States Industry. 25.1 Because this Agreement grants the exclusive right to use or sell the Invention in the United States, LICENSEE Licensee agrees that any products sold in the U.S. embodying this Invention or produced through the use thereof shall will be manufactured substantially in the United States.
Appears in 2 contracts
Sources: Exclusive License Agreement (Atherogenics Inc), Exclusive License Agreement (Atherogenics Inc)
Preference for United States Industry. 25.1 Because this Agreement grants the exclusive right to use or sell the Invention in the United States, LICENSEE the Licensee agrees that any products sold in the U.S. embodying this Invention or produced product through the use thereof shall will be manufactured substantially in the United States. 27.
Appears in 1 contract
Sources: License Agreement (Vyrex Corp)